Roche to Invest $50 Billion in Pharma, Diagnostics in US
This article is for subscribers only.
Roche Holding AG said it will invest $50 billion in the US in the next five years, joining rival drugmakers in trumpeting American expansion plans as President Donald Trump prepares to slap tariffs on pharmaceutical imports.
The Swiss firm will expand and upgrade manufacturing and distribution capabilities in Kentucky, Indiana, New Jersey, Oregon and California. Roche will also build a manufacturing plant to support the expansion of next-generation weight-loss drugs, though it didn’t disclose the location.